GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Small and Large Bowel/CAMs and GI Disorders

CAMs and GI Disorders

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated July 1, 2025

Quick Answer

Complementary and Alternative Medicine (CAM) is increasingly being recognized as a valuable adjunct in the management of gastrointestinal (GI) disorders, particularly as the prevalence of these conditions rises due to modern lifestyle factors such as stress, ultraprocessed diets, obesity, depression, and infections. Below is a detailed exploration of the role of CAM in GI disorders, supported by the context provided: --- ### **Prevalence of CAM Use in GI Disorders** -...


Complementary and Alternative Medicine (CAM) is increasingly being recognized as a valuable adjunct in the management of gastrointestinal (GI) disorders, particularly as the prevalence of these conditions rises due to modern lifestyle factors such as stress, ultraprocessed diets, obesity, depression, and infections. Below is a detailed exploration of the role of CAM in GI disorders, supported by the context provided:

---

### **Prevalence of CAM Use in GI Disorders**

  • **Widespread Use:** Up to 44% of patients with GI disorders use CAM therapies, often without informing their healthcare providers. This highlights the need for physicians to proactively inquire about CAM use to avoid risks of hidden interactions and to provide appropriate guidance.
  • **Patient Appeal:** CAM is attractive to patients because it offers a sense of control, especially when conventional treatments fail to fully resolve symptoms. The holistic approach of CAM addresses not just physical symptoms but also psychological and lifestyle factors.

---

### **Barriers and Opportunities in CAM Integration**

  • **Disclosure Gap:** Many patients do not disclose their use of CAM due to fear of judgment or the belief that it is not clinically relevant, which can lead to missed opportunities for physicians to guide safe and effective use.
  • **Educational Gap:** CAM is rarely covered in medical training, leaving many gastroenterologists unfamiliar with therapies their patients are actively using. Bridging this gap through education and awareness is essential.
  • **Integrative Model:** Experts advocate for an integrative gastroenterology model, combining standard medical care with evidence-based CAM therapies to address the growing burden of GI diseases.

---

### **Evidence-Based CAM Therapies for GI Disorders**

1. **Mind-Body Medicine:**

  • Interventions like cognitive behavioral therapy (CBT), mindfulness, hypnotherapy, and yoga have demonstrated efficacy in functional GI disorders like irritable bowel syndrome (IBS).
  • These therapies are gaining mainstream acceptance as scientific evidence accumulates, particularly in their ability to address the neuro-gut connection.

2. **Nutritional Supplements and Herbal Therapies:**

  • **L-Glutamine:** Effective in postinfectious IBS with diarrhea and intestinal hyperpermeability, supporting gut barrier repair.
  • **Ginger and Vitamin B6:** Evidence-supported treatments for nausea, including pregnancy-related nausea, though caution is advised for ginger in patients on antiplatelet therapy.
  • **Peppermint and Caraway:** Extensively studied for functional dyspepsia, with significant reductions in bloating and epigastric pain.
  • **Curcumin:** Known for its anti-inflammatory effects in the GI tract.
  • **Bovine Colostrum:** Supports mucosal immunity and healing.
  • **Mucosal Protectants:** Compounds like zinc-carnosine, marshmallow root, slippery elm, and licorice support gut barrier function and reduce inflammation. These may also be useful in transitioning patients off proton pump inhibitors (PPIs).

3. **Probiotics:**

  • Specific strains, such as *Saccharomyces boulardii*, help prevent dysbiosis during antibiotic therapy. Targeted probiotics can also be used post-treatment to restore gut health.

4. **Acupuncture:**

  • Widely studied in various GI disorders such as constipation, GERD, IBD, ileus, pancreatitis, and gastroparesis.
  • Functional MRI studies show acupuncture modulates brain connectivity in regions associated with visceral sensation, pain regulation, and emotion, providing mechanistic plausibility for its efficacy.

5. **Herbal Combinations:**

  • **STW-5 (Iberogast):** A combination of multiple herbs, shown to improve symptoms in GERD and epigastric pain, with clinical trials supporting its efficacy.

---

### **Lifestyle and Behavioral Guidance**

  • CAM practitioners emphasize the importance of lifestyle changes to complement medical and CAM treatments. Key recommendations include:
  • Eating slowly and mindfully.
  • Reducing greasy and processed foods.
  • Avoiding lying down immediately after meals.
  • Ensuring adequate fiber intake.

These strategies not only help manage symptoms but also address underlying contributors to GI disorders.

---

### **Evolving Acceptance of CAM in GI Disorders**

  • Therapies once considered fringe, such as mind-body medicine and concepts like intestinal permeability ("leaky gut"), are gaining legitimacy as scientific evidence accumulates.
  • The integrative approach to gastroenterology is increasingly recognized for its potential to accelerate symptom relief, reduce reliance on medications, and improve overall quality of life for patients with functional and inflammatory GI disorders.

---

### **Concerns with Overuse of Conventional Treatments**

  • Overprescription of proton pump inhibitors (PPIs) is a concern, as they are often prescribed without confirming true hyperacidity. This can lead to risks like infections, nutrient malabsorption, and rebound hyperacidity. CAM therapies, such as mucosal protectants and lifestyle changes, may serve as alternatives or adjuncts to reduce reliance on PPIs.

---

### **Clinical Implications**

Gastroenterologists should:

1. Proactively inquire about CAM use during patient consultations.

2. Stay informed about evidence-based CAM therapies to provide safe and effective recommendations.

3. Integrate CAM with standard care to offer a holistic approach to managing GI disorders.

By combining conventional medicine with evidence-supported CAM, healthcare providers can address both the physical and psychological dimensions of GI disorders, ultimately improving patient outcomes and satisfaction.

Related Q&A

Anal High-Grade Squamous Intraepithelial Lesions (HSIL): BJS | March 2026

Introduction: Anal squamous cell carcinoma is an increasingly common but largely preventable cancer. Most cases arise from persistent high-risk human papillomavirus (HPV) infection, progressing through high-grade squamous intraepithelial lesions (HSIL). This comprehensive review summarizes the...

Post-Infection DGBI (PI-DGBI): Gut | July 2026

Introduction: Acute infectious gastroenteritis can trigger persistent gastrointestinal symptoms long after the infection has resolved, leading to post-infection disorders of gut-brain interaction (PI-DGBI). This global Rome Foundation study evaluated the prevalence, risk factors, and clinical...

FMT in IBS: Gastroenterology | July 2026

Introduction: Gut microbiota alterations have been implicated in the pathogenesis of irritable bowel syndrome (IBS), making fecal microbiota transplantation (FMT) a promising therapeutic strategy. However, clinical trials have reported conflicting results. This updated meta-analysis evaluated...

Laparoscopic vs Open Adhesiolysis for Bowel Obstruction: JAMA Surgery | June 2026

Introduction: Laparoscopic adhesiolysis offers several short-term advantages over open surgery for adhesive small bowel obstruction (ASBO). However, its long-term impact on recurrence, quality of life, and incisional hernia remains uncertain. The LASSO trial provides the...

DPP-4 Inhibition Targets the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026

Introduction: Growing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This study investigated whether sitagliptin, a widely used DPP-4 inhibitor for...

Bedside Ultrasound Outperforms Abdominal X-Ray in Neonatal Necrotizing Enterocolitis: Frontiers in Pediatrics | July 2026

Introduction: Necrotizing enterocolitis (NEC) is one of the most serious gastrointestinal emergencies in neonates. Early identification of infants requiring surgical intervention is critical but remains challenging. This study compared bedside abdominal ultrasonography (US) with abdominal...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer